Balyasny Asset Management L.P. bought a new stake in KORU Medical Systems, Inc. (NASDAQ:KRMD – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm bought ...

KORU Medical Systems Inc (NASDAQ:KRMD) achieved record-setting revenues in the fourth quarter, with a 23% increase, and full-year revenues grew by 18%. The company expanded its gross margins ...

Piper Sandler reissued their neutral rating on shares of KORU Medical Systems (NASDAQ:KRMD – Free Report) in a report published on Friday morning, MarketBeat Ratings reports. They currently have a ...

Analyst Price Forecast Suggests 28.67% Upside As of January 29, 2025, the average one-year price target for KORU Medical ...

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical&CloseCurlyDoubleQuote ... a 67% improvement over the prior year “I am proud of the growth that we have achieved in our fourth quarter and 2024 finish ...

Lake Street analyst Frank Takkinen reiterated a Buy rating on REPRO-MED Systems (KRMD – Research Report) today and set a price target of $4.00. The company’s shares closed yesterday at $2.92.

Operating Expense: Approximately $23.5 to $24 million expected for 2024. KORU Medical Systems Inc (NASDAQ:KRMD) reported record revenues of $8.4 million for Q2 2024, marking a 22% growth over the ...

In a report released today, Jason Bednar from Piper Sandler maintained a Buy rating on REPRO-MED Systems (KRMD – Research Report), with a price target of $3.00. The company’s shares closed ...